Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Down 57.8% in January

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totaling 135,611 shares, a decline of 57.8% from the December 31st total of 321,082 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average trading volume of 82,847 shares, the days-to-cover ratio is currently 1.6 days. Based on an average trading volume of 82,847 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.4% of the company’s stock are sold short.

Adlai Nortye Stock Performance

NASDAQ:ANL opened at $10.63 on Friday. The stock’s 50 day moving average price is $1.92 and its two-hundred day moving average price is $1.72. Adlai Nortye has a 12-month low of $0.88 and a 12-month high of $11.05.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.